Balanced news tone
News Sentiment
SRPT sentiment intelligence
SAREPTA THERAPEUTICS INC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
48
Balanced news tone
32 relevant articles
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +4.6% over four weeks, trend inactive, and below fair value.
Sarepta Therapeutics Stock Short Interest Rises to 32.62%
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
83/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend inactive
4.6% over four weeks
Fair value
-59.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
18
Negative
7
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Clinical Trials Arena
Direct company coverage
Sarepta share price drops again after third gene therapy death
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jul 2025 07:00
- Source
- Clinical Trials Arena
Reuters
Direct company coverage
Sarepta shares slump after third patient death this year
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Jul 2025 07:00
- Source
- Reuters